Fever is a common clinical symptom, often indicating the body's response to pathogenic invasion or inflammation. Despite its frequency, fever management in clinical practice remains a complex task requiring thorough understanding and careful application of knowledge.
The pathophysiology of fever involves the production of pyrogens, substances that trigger the hypothalamus to raise the body's set-point temperature. Pyrogens can be endogenous, produced by the body, or exogenous, introduced by external agents such as bacteria and viruses.
Accurate assessment and diagnosis are crucial in fever management. Clinicians should conduct a comprehensive history and physical examination, considering factors such as age, travel history, and immune status. Diagnostic tests, including blood cultures and imaging, may be necessary based on the patient's presentation.
Treatment of fever involves addressing the underlying cause and providing symptomatic relief. Antipyretics, such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), are commonly used for symptomatic management. Antimicrobial therapy may be indicated if an infection is identified. It is crucial to monitor patients closely for potential side effects and response to treatment.
Management strategies may differ in special populations, such as children, the elderly, and immunocompromised patients. For instance, in children, fever without source (FWS) is a common concern, requiring a tailored approach to evaluation and management. Similarly, in the elderly and immunocompromised, atypical presentations may complicate diagnosis and management.
In conclusion, fever management in clinical practice is multifaceted, requiring a comprehensive understanding of its etiology, assessment, diagnosis, and treatment strategies. Clinicians should remain vigilant and adaptable, recognizing that management strategies may need to be tailored based on the patient's individual circumstances and the underlying cause of the fever.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation